CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | O'Neill Vincent Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2023-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2023-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-03-15 | Rodriguez Javier See Remarks | Sale | −950 | $19.63 | $19K | 1,135 |
| 2023-03-15 | Rodriguez Javier See Remarks | Grant or award · Restricted Stock Units | +9,000 | 9,000 | ||
| 2023-03-15 | Rodriguez Javier See Remarks | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2023-03-14 | Steinhart Richard I Chief Financial Officer | Option exercise | +2,084 | 3,584 | ||
| 2023-03-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −2,084 | 6,253 | ||
| 2023-03-14 | Yocca Frank Chief Scientific Officer | Option exercise | +2,084 | 10,481 | ||
| 2023-03-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,084 | 6,253 | ||
| 2023-03-14 | Mehta Vimal CEO and President | Option exercise | +10,437 | 20,394 | ||
| 2023-03-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −10,437 | 31,313 | ||
| 2023-03-14 | O'Neill Vincent Chief Medical Officer | Option exercise | +2,084 | 2,084 | ||
| 2023-03-14 | O'Neill Vincent Chief Medical Officer | Option exercise · Restricted Stock Units | −2,084 | 6,253 | ||
| 2023-03-14 | Rodriguez Javier See Remarks | Option exercise | +2,084 | 2,084 | ||
| 2023-03-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −2,084 | 6,253 | ||
| 2023-01-20 | Yocca Frank Chief Scientific Officer | Sale | −50,000 | $30.00 | $1.5M | 8,397 |
| 2023-01-20 | O'Neill Vincent Chief Medical Officer | Option exercise | +29,713 | $0.41 | $12K | 29,713 |
| 2023-01-20 | O'Neill Vincent Chief Medical Officer | Sale | −29,713 | $30.00 | $891K | 0 |
| 2023-01-20 | O'Neill Vincent Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −29,713 | 29,712 |
Page 20 of 27 · 521 trades